|
Volumn 21, Issue 5, 2013, Pages 1344-1348
|
Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: Synthesis, crystallography, modeling, kinetic and cellular based studies
b
USA
(United States)
|
Author keywords
Adamantane derivatives; Botulinum neurotoxin; Protease inhibitor; Small molecule inhibitor; Zinc dependent metalloprotease
|
Indexed keywords
1 ADAMANTYL N HYDROXYACETAMIDE;
1 ADAMANTYLACETIC ACID;
1 ADAMANTYLACETOHYDROXAMIC ACID;
ADAMANTANE DERIVATIVE;
BOTULINUM TOXIN;
BOTULINUM TOXIN A;
HYDROXAMIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CELL KINETICS;
COMPETITIVE INHIBITION;
COMPUTER MODEL;
DRUG BINDING SITE;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
STRUCTURE ACTIVITY RELATION;
X RAY CRYSTALLOGRAPHY;
ADAMANTANE;
ANIMALS;
BINDING SITES;
BOTULINUM TOXINS, TYPE A;
CATALYTIC DOMAIN;
CELLS, CULTURED;
CRYSTALLOGRAPHY, X-RAY;
DRUG EVALUATION, PRECLINICAL;
HYDROXAMIC ACIDS;
KINETICS;
MOLECULAR DOCKING SIMULATION;
PROTEASE INHIBITORS;
RATS;
STEM CELLS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84873722654
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.12.001 Document Type: Article |
Times cited : (49)
|
References (26)
|